Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Open in API
Filings indexed 1,118 across all filing types
Latest filing 2023-05-30 Major Shareholding Noti…
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
Change in substantial holding 3 pages 316.1KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under Corporations Law Section 671B. It details changes in voting power and relevant interests of a substantial shareholder (Viburnum Funds Pty Ltd) in Mayne Pharma Group Limited. This type of filing is a notification of changes in significant share ownership levels, which matches the definition of Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report, but a regulatory disclosure of shareholding changes.
2023-05-30 English
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is a detailed notification about a company's on-market buy-back of its own shares, including daily updates on the number of shares bought back, prices paid, broker information, and regulatory compliance details. It specifically mentions 'Notification of buy-back' multiple times and provides daily buy-back data as required by listing rules. This type of document is a report of the company buying back its own shares, which fits the category 'Transaction in Own Shares' (POS). The document length and content confirm it is not a brief announcement or a regulatory filing but a substantive update on share repurchase activity.
2023-05-29 English
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is a detailed notification about a company's on-market buy-back of its own shares. It includes specifics such as the number of securities bought back, dates, prices paid, broker information, and regulatory compliance details. The text repeatedly refers to 'buy-back' and 'on-market buy-back' and provides daily updates on the buy-back activity. This matches the definition of a Transaction in Own Shares (POS) filing, which reports the company buying back its own shares. The document is not an announcement of a report, nor is it a financial report or regulatory certification. Therefore, the correct classification is POS with high confidence.
2023-05-28 English
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is a detailed notification about a company's on-market share buy-back activity, including daily updates on the number of shares bought back, prices paid, broker information, and regulatory compliance details. It specifically mentions 'Daily buy-back notification' multiple times and provides granular data on the buy-back transactions. This matches the description of a 'Transaction in Own Shares' filing, which reports the company's repurchase of its own shares. The document is not an announcement of a report or a general regulatory filing but a specific transaction update. Therefore, the correct classification is POS (Transaction in Own Shares).
2023-05-25 English
Update - Notification of buy-back - MYX 5 pages 25.3KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Notification of buy-back' and contains detailed information about an on-market share buy-back program by Mayne Pharma Group Limited. It includes specifics such as the type of buy-back, broker appointment, dates, and conditions. The content is an announcement regarding the company's share repurchase activity rather than a full financial report or other regulatory filing. The document length is 3454 characters, which is relatively short and focused on the buy-back update. Therefore, it fits the category of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares.
2023-05-24 English
Update - Notification of buy-back - MYX 5 pages 25.3KB
Transaction in Own Shares Classification · 100% confidence The document is a notification regarding a buy-back of shares by Mayne Pharma Group Limited. It includes details such as the type of buy-back (on-market), dates, broker information, and correction to a previous announcement. The content is focused on the company's repurchase of its own shares and does not contain financial statements or performance data. The document length is 3450 characters, which is relatively short and is an announcement rather than a full report. Therefore, it fits the category of a Transaction in Own Shares (POS) filing, which covers share repurchase announcements.
2023-05-24 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.